The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Molecular mediators of hepatic steatosis and liver injury
Open accessAbstract
Nonstandard abbreviations used: acetyl-CoA carboxylase (ACC); AMP-activated protein kinase (AMPK); basic helix-loop-helix-leucine zipper (bHLH-Zip); carbohydrate response element binding protein (ChREBP); carnitine palmitoyl transferase-1 (CPT-1); diethylaminoethoxyhexestrol (DEAEH); liver function test (LFT); liver-type pyruvate kinase (L-PK); malondialdehyde (MDA); mitochondrial respiratory chain (MRC); nonalcoholic fatty-liver disease (NAFLD); nonalcoholic steatohepatitis (NASH); polyunsaturated fatty acid (PUFA); reactive oxygen species (ROS); stearoyl-CoA desaturase (SCD); trans-4-hydroxy-2-nonenal (HNE). Conflict of interest:The authors have declared that no conflict of interest exists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ectopic triglycerides usually signify the presence of long-chain free fatty acids, which are cytotoxic (15,16) and believed to interfere with normal insulin signaling leading to insulin resistance.”
From Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy (2005) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Weight-Reducing Effects of the Plasma Protein Encoded by the obese Gene
Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Self-citationBrown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,564
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander‐Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,166
Research works printed but not linked: 1
- Garcia-Ruiz, 1995, Mol. Pharmacol., 48, 825
Cited by
Sorted by citations
Items 901–1,000 of 1,005
Hanhineva, K., Barri, T., Kolehmainen, M., Pekkinen, J., Pihlajamäki, J., Vesterbacka, A., Solano-Aguilar, G. I., Mykkänen, H. M., Dragsted, L. O., Urban, J. F., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr400257d · Cited by 41
Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis
Le, T., & Loomba, R. S. (2012) · Journal of Clinical and Experimental Hepatology · doi:10.1016/s0973-6883(12)60104-2 · Cited by 41
Resistance to Diet-Induced Obesity in Mice with Synthetic Glyoxylate Shunt
Dean, J. T., Tran, L. M., Beaven, S. W., Tontonoz, P., Reue, K., Dipple, K. M., & Liao, J. C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.04.008 · Cited by 41
Fortibui, M. M., Park, C., Kim, N. Y., Kim, T. H., & Lee, M. H. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c00270 · Cited by 40
Enjoji, M., & Nakamuta, M. (2010) · PubMed Central · doi:10.3748/wjg.v16.i7.800 · Cited by 40
Update on Ppar and Nonalcoholic Fatty Liver Disease
Ables, G. P. (2012) · PPAR Research · doi:10.1155/2012/912351 · Cited by 40
Zhang, J.-M., Tan, Y., Yao, F., & Zhang, Q. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1015 · Cited by 40
Maurantonio, M., Ballestri, S., Odoardi, M. R., Lonardo, A., & Loria, P. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.08.004 · Cited by 40
Matsunami, T., Sato, Y., Ariga, S., Sato, T., Shimomura, T., Kashimura, H., Hasegawa, Y., & Yukawa, M. (2010) · Metabolism · doi:10.1016/j.metabol.2010.07.032 · Cited by 40
Xu, J., Li, L., Wang, Y. Q., Li, Y., Shan, M., Sun, S., Yu, Y. W., & Wang, B. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m077016 · Cited by 40
Friedrich, D., Marschall, H., & Lammert, F. (2018) · BMC Gastroenterology · doi:10.1186/s12876-018-0805-z · Cited by 40
Green, C., Parry, S. A., Gunn, P. J., Ceresa, C. D. L., Rosqvist, F., Piché, M., & Hodson, L. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0038 · Cited by 40
MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease
Yu, J., Peng, J., Luan, Z., Zheng, F., & Su, W. (2019) · Molecules · doi:10.3390/molecules24020230 · Cited by 40
Gómez‐Zorita, S., Aguirre, L., Milton‐Laskibar, I., Fernández‐Quintela, A., Trepiana, J., Kajarabille, N., Mosqueda-Solís, A., González, M. A., & Portillo, M. P. (2019) · Nutrients · doi:10.3390/nu11092156 · Cited by 40
Ye, L., Cao, Z., Lai, X., Shi, Y., & Zhou, N. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz303 · Cited by 40
Role of the Sterol Regulatory Element Binding Protein Pathway in Tumorigenesis
Jiang, T., Zhang, G., & Lou, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01788 · Cited by 41
Xu, H., Jiang, Y., Miao, X., Tao, Y., Xie, L., & Li, Y. (2021) · Biology · doi:10.3390/biology10020092 · Cited by 40
Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis
Sletten, A. C., Davidson, J. W., Yağabasan, B., Moores, S., Schwaiger-Haber, M., Fujiwara, H., Gale, S. E., Jiang, X., Sidhu, R., Gelman, S. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25457-y · Cited by 40
Zhang, Y., Ye, S., Lu, W.-J., Zhong, J., Leng, Y., Yang, T., Luo, J., Xu, W., Zhang, H., & Kong, L. (2022) · Hepatology · doi:10.1002/hep.32651 · Cited by 40
Zheng, J., Li, C., & Zheng, X. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.136362 · Cited by 40
Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice
Chen, W., Chen, C., Liu, C., & Mao, F. C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.129 · Cited by 40
Clusterin Decreases Hepatic SREBP-1c Expression and Lipid Accumulation
Seo, H.-Y., Kim, M. K., Jung, Y., Jang, B. K., Yoo, E.-K., Park, K., & Lee, I. (2013) · Endocrinology · doi:10.1210/en.2012-2009 · Cited by 40
Karavia, E. A., Papachristou, D. J., Kotsikogianni, I., Triantaphyllidou, I., & Kypreos, K. E. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.02.007 · Cited by 40
Lauressergues, E., Martin, F., Helleboid‐Chapman, A., Bouchaert, E., Cussac, D., Bordet, R., Hum, D. W., Luc, G., Majd, Z., Staels, B., et al. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0597-3 · Cited by 40
Li, M., Meng, X., Xu, J., Huang, X., Li, H., Li, G., Wang, S., Man, Y., Tang, W., & Li, J. (2016) · Scientific Reports · doi:10.1038/srep25237 · Cited by 40
Liao, H., He, Y., Zhang, S., Kang, X., Yang, X., Xu, B., Magnuson, J. T., Wang, S., Zheng, C., & Qiu, W. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.4c07056 · Cited by 39
Radler, U., Stangl, H., Lechner, S., Lienbacher, G., Krepp, R., Zeller, E., Brachinger, M., Eller-Berndl, D., Fischer, A., Anzur, C., et al. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000327150 · Cited by 39
Bae, C., Hino, J., Hosoda, H., Arai, Y., Son, C., Makino, H., Tokudome, T., Tomita, T., Kimura, T., Nojiri, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10240-1 · Cited by 39
Olaniyi, K. S., & Amusa, O. A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110226 · Cited by 39
He, Z., Guo, T., Cui, Z., Xu, J., Wu, Z., Yang, X., Hu, H., Mei, H., Zhou, J., Zhang, Y., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.148 · Cited by 39
Sinha‐Hikim, A. P., Sinha‐Hikim, I., & Friedman, T. C. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00023 · Cited by 39
Overindulgence and metabolic syndrome: is FoxO1 a missing link?
Sparks, J. D., & Sparks, C. E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35693 · Cited by 39
Fat and carbohydrate in western diet contribute differently to hepatic lipid accumulation
Wu, W., Tsuchida, H., Kato, T., Niwa, H., Horikawa, Y., Takeda, J., & Iizuka, K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.092 · Cited by 38
Group IVA phospholipase A 2 participates in the progression of hepatic fibrosis
Ishihara, K., Miyazaki, A., Nabe, T., Fushimi, H., Iriyama, N., Kanai, S., Sato, T., Uozumi, N., Shimizu, T., & Akiba, S. (2012) · The FASEB Journal · doi:10.1096/fj.12-205625 · Cited by 38
Rey, J. W. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i46.5830 · Cited by 38
Inhibition of Serotonin Synthesis Induces Negative Hepatic Lipid Balance
Namkung, J., Shong, K. E., Kim, H., Oh, C., Park, S., & Kim, H. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.0084 · Cited by 38
Ren, J., Jin, M., You, Z.-X., Luo, M., Yin, H., Li, G.-C., & Liu, H. (2018) · Sleep And Breathing · doi:10.1007/s11325-018-1741-4 · Cited by 38
Khan, M. I., Shin, J. H., Shin, T. S., Kim, M. Y., Cho, N. J., & Kim, J. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208556 · Cited by 38
Implantable Vascularized Liver Chip for Cross‐Validation of Disease Treatment with Animal Model
Lee, J. B., Park, J. S., Shin, Y. M., Lee, D. H., Yoon, J., Kim, D., Ko, U. H., Kim, Y., Bae, S. H., & Sung, H. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201900075 · Cited by 38
Park, E.-O., Bae, E. J., Park, B., & Chae, S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041147 · Cited by 38
Bae, S. J., Kim, J. E., Choi, H. J., Choi, Y. J., Lee, S. J., Gong, J. E., Seo, S., Yang, S. Y., An, B., Lee, H. S., et al. (2020) · Molecules · doi:10.3390/molecules25112662 · Cited by 38
Selenoprotein F knockout leads to glucose and lipid metabolism disorders in mice
Zheng, X., Ren, B., Li, X., Yan, H., Xie, Q., Liu, H., Zhou, J., Tian, J., & Huang, K. (2020) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-020-01821-z · Cited by 38
Cannabinoid receptor 1 signaling in hepatocytes and stellate cells does not contribute to NAFLD
Wang, S., Zhu, Q., Liang, G., Franks, T., Boucher, M., Bence, K. K., Lu, M., Castorena, C. M., Zhao, S., Elmquist, J. K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci152242 · Cited by 38
Self-citationXie, L. Y., Wen, K., Li, Q., Huang, C., Zhao, J.-L., Zhao, Q., Xiao, Y., Guan, X., Qian, Y., Gan, L., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.65588 · Cited by 38
Xiao, W., Ren, M., Zhang, C., Li, S., & An, W. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00133.2014 · Cited by 38
Chang, M. I., Puder, M., & Gura, K. M. (2012) · Nutrients · doi:10.3390/nu4121828 · Cited by 38
Feng, Q., Gou, X., Meng, S., Huang, C., Zhang, Y., Tang, Y., Wang, W., Xu, L., Peng, J., & Hu, Y. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/184358 · Cited by 38
Lysosomal Cathepsin D contributes to cell death during adipocyte hypertrophy
Eguchi, A., & Feldstein, A. E. (2013) · Adipocyte · doi:10.4161/adip.24144 · Cited by 38
Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease
Alkhouri, N., Carter-Kent, C. A., Elias, M., & Feldstein, A. E. (2011) · Clinical Lipidology · doi:10.2217/clp.11.19 · Cited by 38
Pereira, R. R., de Abreu, I. C. M. E., Guerra, J. F. D. C., Lage, N. N., Lopes, J. M. M., Silva, M. A., de Lima, W. G., Silva, M. E., & Pedrosa, M. L. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8379105 · Cited by 38
Liu, B., Yang, T., Luo, Y., Zeng, L., Shi, L., Wei, C., Nie, Y., Cheng, Y., Lin, Q., & Luo, F. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.12.045 · Cited by 38
de Souza, C. T., ARAUJO, E. P. D., Prada, P. O., Saad, M. J. A., Boschero, A. C., & Velloso, L. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1866-4 · Cited by 38
A Protective Role for CD154 in Hepatic Steatosis in Mice
Villeneuve, J., Lepreux, S., Mulot, A., Bérard, A. M., Higa-Nishiyama, A., Costet, P., de Lédinghen, V., Bioulac‐Sage, P., Balabaud, C. P., Nurden, A. T., et al. (2010) · Hepatology · doi:10.1002/hep.23935 · Cited by 38
Xia, Q., Chiang, H., Yin, J., Chen, S., Cai, L., Yu, H., & Fu, P. P. (2013) · Toxicology and Industrial Health · doi:10.1177/0748233713484648 · Cited by 37
Damiani, D., Kuba, V. M., Cominato, L., Damiani, D., Dichtchekenian, V., & Filho, H. C. D. M. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000800011 · Cited by 37
Park, S. M., Ki, S. H., Han, N. R., Cho, I. J., Ku, S., Kim, S. C., Zhao, R., & Kim, Y. W. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00430 · Cited by 38
Multidisciplinary Pharmacotherapeutic Options for Nonalcoholic Fatty Liver Disease
Nakajima, K. (2012) · International Journal of Hepatology · doi:10.1155/2012/950693 · Cited by 37
Biogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion
Blade, A. M., Fabritius, M. A., Hou, L., Weinberg, R. B., & Shelness, G. S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m010793 · Cited by 37
Li, X.-X., Lu, X.-Y., Zhang, S., Chiu, A. P., Lo, L. H., Largaespada, D. A., Chen, Q.-B., & Keng, V. W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.019 · Cited by 37
Lee, S. J., Kang, J. S., Kim, H. M., Lee, E. Y., Lee, J.-H., Chung, C. H., & Lee, E. Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222352 · Cited by 37
Dairy Foods and Dairy Fats: New Perspectives on Pathways Implicated in Cardiometabolic Health
Hirahatake, K. M., Bruno, R. S., Bolling, B. W., Blesso, C. N., Alexander, L. M., & Adams, S. H. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz105 · Cited by 37
Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
Wattacheril, J. J. (2019) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.10.002 · Cited by 37
Matsumoto, M., Yashiro, H., Ogino, H., Aoyama, K., Nambu, T., Nakamura, S., Nishida, M., Wang, X., Erion, D. M., & Kaneko, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228212 · Cited by 37
CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis
Yu, L., Li, Y., Grisé, A., & Wang, H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6082-8_13 · Cited by 39
Barchetta, I., Ceccarelli, V., Cimini, F. A., Barone, E., Sentinelli, F., Coluzzi, M., Chiappetta, C., Bertoccini, L., Tramutola, A., Labbadia, G., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01392-5 · Cited by 37
Guimarães, V. H. D., Lelis, D. D. F., Oliveira, L. P., Borém, L. M. A., Guimarães, F. A. D., Farias, L. C., de Paula, A. M. B., Guimarães, A. L. S., & Santos, S. H. S. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1835986 · Cited by 37
Hong, J.-H., Hwang, E.-Y., Kim, H. J., Jeong, Y., & Lee, I. S. (2009) · Journal of Medicinal Food · doi:10.1089/jmf.2008.1240 · Cited by 37
Janorkar, A. V., Harris, L. M., Murphey, B., & Sowell, B. L. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.23025 · Cited by 37
Shen, L., Cui, A., Xue, Y., Cui, Y., Dong, X., Gao, Y., Yang, H., Fang, F., & Chang, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.526343 · Cited by 37
Effect of Pancreaticoduodenectomy on the Course of Hepatic Steatosis
Yu, H., Shan, Y., & Lin, P. (2010) · World Journal of Surgery · doi:10.1007/s00268-010-0636-8 · Cited by 37
Krautbauer, S., Eisinger, K., Lupke, M., Wanninger, J., Ruemmele, P., Hader, Y., Weiß, T. S., & Buechler, C. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.10.003 · Cited by 37
Lisi, S., Gamucci, O., Vottari, T., Scabia, G., Funicello, M., Marchi, M., Galli, G., Arisi, I., Brandi, R., D’Onofrio, M., et al. (2011) · Diabetes · doi:10.2337/db10-1536 · Cited by 37
Shin, E., Shim, K.-S., Kong, H., Lee, S., Shin, S., Kwon, J., Jo, T. H., Park, Y.-I., Lee, C., & Kim, K. (2011) · Immune Network · doi:10.4110/in.2011.11.1.59 · Cited by 37
Vatsalya, V., Song, M., Schwandt, M. L., Cave, M. C., Barve, S. S., George, D. T., Ramchandani, V. A., & McClain, C. J. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13197 · Cited by 37
Ma, Z., Huang, Z., Zhang, C., Liu, X., Zhang, J., Shu, H., Ma, Y., Liu, Z., Feng, Y. Y., Chen, X., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05829-9 · Cited by 36
n−3 Fatty acids ameliorate hepatic steatosis and dysfunction after LXR agonist ingestion in mice
Jung, U. J., Millman, P. N., Tall, A. R., & Deckelbaum, R. J. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.06.003 · Cited by 36
Induction of NAFLD with Increased Risk of Obesity and Chronic Diseases in Developed Countries
Martins, I. J. (2014) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2014.44011 · Cited by 36
Metabolic Factors and Chronic Hepatitis C: A Complex Interplay
Macaluso, F. S., Maida, M. F., Minissale, M. G., Vigni, T. L., Attardo, S., Orlando, E., & Petta, S. (2013) · BioMed Research International · doi:10.1155/2013/564645 · Cited by 36
Kikuchi, K., Nezu, U., Inazumi, K., Miyazaki, T., Ono, K., Orime, K., Shirakawa, J., Sato, K., Koike, H., Wakasugi, T., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12427 · Cited by 36
Apolipoprotein A-V dependent modulation of plasma triacylglycerol: A puzzlement
Sharma, V., Ryan, R. O., & Forte, T. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.12.002 · Cited by 36
Yang, M., Chan, K., Lee, Y., Chang, X.-Z., Wu, C., & Wang, C. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b00346 · Cited by 36
Lidofsky, S. D. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0006-1 · Cited by 36
Cross Talk Between Cellular Redox State and the Antiapoptotic Protein Bcl-2
Pohl, S., Agostino, M., Dharmarajan, A., & Pervaiz, S. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7414 · Cited by 36
Chae, H., You, B. H., Kim, D.-Y., Lee, H., Ko, H. W., Ko, H., Choi, Y. H., Choi, S. S., & Chin, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-24935-6 · Cited by 36
Chen, H., Ng, J. P. M., Bishop, D., MILTHORPE, B. K., & Valenzuela, S. M. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0414-6 · Cited by 36
High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype
Golob‐Schwarzl, N., Bettermann, K., Mehta, A. K., Kessler, S. M., Unterluggauer, J. J., Krassnig, S., Kojima, K., Chen, X., Hoshida, Y., Bardeesy, N. M., et al. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.10.010 · Cited by 36
Zhou, Z., Qi, J., Lim, C. W., Kim, J.-W., & Kim, B. (2020) · Toxicology · doi:10.1016/j.tox.2020.152579 · Cited by 36
Lu, S., Kuang, M., Yue, J., Hu, C., Sheng, G., & Zou, Y. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01712-z · Cited by 36
Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity
Park, J. S., Kang, D. H., Lee, D. H., & Bae, S. H. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.120 · Cited by 36
Obstructive sleep apnea is associated with liver disease: a population-based cohort study
Chou, T., Liang, W.-M., Wang, C., Wu, T.-N., & Hang, L. (2015) · Sleep Medicine · doi:10.1016/j.sleep.2015.02.542 · Cited by 36
Cytokines and chronic liver disease
Fainboim, L., Cherñavsky, A. C., Paladino, N., Flores, A. C., & Arruvito, L. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.01.017 · Cited by 36
Metabolic Syndrome in Pediatrics: Old Concepts Revised, New Concepts Discussed
D’Adamo, E., Santoro, N., & Caprio, S. (2013) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2013.02.004 · Cited by 36
Binge Ethanol-Induced HDAC3 Down-RegulatesCpt1αExpression Leading to Hepatic Steatosis and Injury
Kirpich, I., Zhang, J., Gobejishvili, L., Kharebava, G., Barker, D. F., Ghare, S. S., Joshi‐Barve, S., McClain, C. J., & Barve, S. S. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12172 · Cited by 36
Ozawa, T., Maehara, N., Kai, T., Arai, S., & Miyazaki, T. (2016) · Genes to Cells · doi:10.1111/gtc.12446 · Cited by 36
Huo, X., Yang, S., Sun, X., Meng, X., & Zhao, Y. (2018) · Molecules · doi:10.3390/molecules23071623 · Cited by 36
RetractedLee, Y., & Friedman, S. L. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385233-5.00006-4 · Cited by 37
Kawahara, H., Fukura, M., Tsuchishima, M., & Takase, S. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00287.x · Cited by 36
Triglycerides Potentiate the Inflammatory Response in Rat Kupffer Cells
Budick-Harmelin, N., Dudás, J., Demuth, J. E., Madar, Z., Ramadori, G. P., & Tirosh, O. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1876 · Cited by 36
MYC: there is more to it than cancer
Fluck, M. F. Z., Soucek, L., & Whitfield, J. R. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1342872 · Cited by 35
Gu, S., Aa, J., Wang, G., Zha, W., Yan, B., Zhang, Y., Ren, H., Cao, B., & Liu, L. (2009) · Biomedical Chromatography · doi:10.1002/bmc.1279 · Cited by 35
Metadata
- Authors
- Browning, J. D., & Horton, J. D.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Horton, Jay D.
- ORCID
- Horton, Jay D.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-07-15
- Volume
- 114
- Issue
- 2
- Pages
- 147-152
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC449757
- OpenAlex
- W4230280576
- Cited by
- 1,772
- References
- 82
- Citations by year
- 2026: 18 · 2025: 32 · 2024: 45 · 2023: 50 · 2022: 73 · 2021: 72 · 2020: 75 · 2019: 100 · 2018: 104 · 2017: 89 · 2016: 102 · 2015: 109 · 2014: 90 · 2013: 104 · 2012: 103
- FWCI
- 48.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- Funders
- American Liver Foundation
- National Institutes of Health (HL20948)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- hepatic steatosis, liver injury, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, molecular mediators, lipid metabolism, reactive oxygen species, oxidative stress, mitochondrial dysfunction, lipid peroxidation, acetyl-CoA carboxylase, AMPK, ChREBP, stearoyl-CoA desaturase, polyunsaturated fatty acids, malondialdehyde
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review